Purpose: To explore the relationship among parameters of magnetic resonance spectroscopy (MRS) and amide proton transfer (APT) imaging, and to assess the diagnostic performance of MRS and APT imaging for grading brain tumors in comparison with contrast enhancement of conventional MRI for preoperative grading in patients with brain tumor. Materials and Methods: Institutional Review Board approval and written informed consent were obtained. Forty-one patients with suspected brain tumors were enrolled in the study. Single-voxel MRS and 2D APT imaging of the same slice level were conducted using a 3T MRI scanner. Positive or negative contrast enhancement on T 1 -weighted images was assessed by two neuroradiologists. Correlations among metabolite concentrations, metabolite ratios, and calculated histogram parameters, including mean APT (APT mean ) and the 90th percentile of APT (APT 90 ) were assessed using Spearman's correlation coefficient. Diagnostic performance was evaluated with receiver operating characteristic (ROC) curve analysis for contrast enhancement and MRS and APT imaging. Values of P < 0.05 were considered statistically significant. Results: Positive correlations with statistical significance were found between total concentration of choline (Cho) and APT 90 (r 5 0.49), and between Cho/creatine (Cr) and APT mean (r 5 0.65) as well as APT 90 (r 5 0.49). A negative correlation with statistical significance was observed between NAA/Cr and APT mean (r 5 20.52). According to ROC curves, Cho/Cr, APT mean , APT 90 , demonstrated higher area under the curve (AUC) values than that of contrast enhancement in grading gliomas. Conclusion: Significant correlations were observed between metabolite concentrations and ratios on MRS and APT values. MRS and APT imaging showed comparable diagnostic capability for grading brain tumors, suggesting that both MRS and APT imaging offer potential for quantitatively assessing similar biological characteristics in brain tumors on noncontrast MRI. Level of Evidence: 2 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2017;46:732-739 C onventional magnetic resonance imaging (MRI) with a gadolinium-based contrast agent has been accepted as a standard method for the characterization of brain tumors. In particular, disruption of the blood-brain barrier (BBB) as observed on contrast-enhanced (CE) T 1 -weighted imaging is used as a measure of brain tumor malignancy and grading. 1 However, the accuracy of this approach is reportedly limited.
C onventional magnetic resonance imaging (MRI) with a gadolinium-based contrast agent has been accepted as a standard method for the characterization of brain tumors. In particular, disruption of the blood-brain barrier (BBB) as observed on contrast-enhanced (CE) T 1 -weighted imaging is used as a measure of brain tumor malignancy and grading. 1 However, the accuracy of this approach is reportedly limited. 2, 3 Moreover, with the recent availability of antiangiogenic pharmacotherapies such as bevacizumab and other agents, 4, 5 evaluating the status of brain tumors has been complicated by the protection of the BBB afforded by these treatments. 6 Several studies have investigated the visualization and characterization of brain tumors without using contrast media. Among these, 1 H-magnetic resonance spectroscopy (MRS) has been established as a technique providing information on chemical metabolites present in living tissues. 7 Amide proton transfer (APT) imaging, a novel chemical exchange saturation transfer (CEST)-based molecular MRI technique, has recently been introduced to the clinical setting. [8] [9] [10] [11] [12] APT imaging is designed to detect endogenous mobile proteins and peptides in tissues. 13 Both MRS and APT imaging provide metabolic information that can be exploited to study the biological behaviors of tumors. 14, 15 We assumed that APT imaging and metabolites identified on MRS would show similarities and correlations and would provide important oncologic information. To date, several studies have demonstrated that these advanced techniques have the potential to characterize brain tumors. [7] [8] [9] [10] [11] [12] [16] [17] [18] However, very few clinical studies have discussed correlations between findings from MRS and APT imaging. 19 The objectives of this study were to: 1) explore relationships among parameters obtained from MRS and APT imaging, and 2) assess the diagnostic performance of APT imaging and MRS for grading brain tumors in comparison with contrast enhancement of conventional MRI.
Materials and Methods

Patients
The Institutional Review Board of our university approved this study. Written informed consent was obtained from all patients or their guardian/s. Between May 2013 and August 2014, a total of 41 consecutive patients with suspected brain tumor and symptoms corresponding to World Health Organization (WHO) performance status 2 were enrolled in the study. The following inclusion criteria were used: 1) MRS and APT imaging performed during the same examination, and 2) presence of treatment-na€ ıve or recurrent tumor with histological verification. Exclusion criteria were: i) degradation of image quality due to susceptibility artifacts or motion artifacts; ii) unsatisfactory shimming such as a larger full-width at half-maximum (FWHM) of water peak reaching >0.10 ppm; or iii) extra-axial tumors such as meningioma. When motion artifacts were suspected, the original series of APT imaging were visually inspected if there were apparent movements of head position during image acquisition. Five patients were excluded due to severe motion artifacts during APT imaging (i), five patients were excluded due to the FWHM criterion (ii), and four patients with lymphoma, one patient with brain metastasis from melanoma, five patients with meningioma were also excluded (iii). A final total of 21 patients were thus included in this study.
MRI
MRS. All MRIs were performed using a whole-body 3T system (Vantage; Toshiba Medical Systems, Otawara, Japan) with a 32-channel head coil. MRS was obtained using a single-voxel point-resolved , depending on tumor size.
MR data were transferred to a workstation, then MRS was analyzed using LCModel v. 6.3-0C software (LCModel, Ontario, Canada) using the basis set. Analysis was undertaken on watersuppressed spectral domain data for chemical shifts in the range of 0.0-4.0 ppm. Absolute concentrations of N-acetyl aspartate (NAA), creatine (Cr), and choline (Cho), and NAA to creatine ratio (NAA/Cr) and choline to creatine (Cho/Cr) ratios were calculated using known concentrations of tissue water. 20 APT IMAGING. APT imaging was conducted with a 2D fast advanced spin echo sequence, which is similar to the half-Fourier acquisition single-shot turbo spin-echo sequence. The imaging slice was set at the midpoint of the VOI of MRS, which enabled values of APT to be obtained at the VOI of MRS. The following parameters were used in a single-slice axial acquisition: field of view, 230 3 230 mm; matrix, 256 3 256; TR, 9000 msec; TE, 60 msec; flip angle, 908; refocusing flip angle, 1608; slice thickness, 5 mm; bandwidth, 651 Hz/pixel; saturation power, flip angle 5008 (1 lT); magnetization-transfer (MT) contrast pulse shot, 25; interpulse delay, 1 msec; and scan time, 6 minutes 9 seconds. MT spectra over an offset range of 610 ppm with a step size of 0.5 ppm with respect to water resonance were obtained.
Imaging Analysis
CONVENTIONAL MRI. Two board-certified neuroradiologists (A.S. and Y.F. with 8 and 17 years of experience, respectively) independently analyzed imaging characteristics of brain tumor. They assessed if contrast enhancement is present (CE 1 ve) or not (CE -ve) on CE T 1 -weighted image of patients with brain tumor.
APT IMAGING. The minimum value for MT spectra obtained from APT imaging was estimated from the original data by spline interpolation with Lorentzian function fitting, and displacement from the water resonance frequency owing to B 0 -field inhomogeneity was corrected. For quantification, asymmetric magnetization transfer ratio (MTR asym ) analysis was performed with respect to the water resonance frequency on the shift-corrected z-spectrum fit between a parameter for amide proton exchange and its symmetrically opposite side, such that MTR asym (1Dx) 5 MTR(-Dx) -MTR(1Dx), where MTR is the magnetization transfer ratio and Dx is the frequency (in ppm) of amide and the water exchange site with respect to water (typically between 3.3 and 3.7 ppm) obtained from the shiftcorrected z-spectrum. The VOI of MRS was automatically transferred to the APT image of each patient using an in-house script in MatLab 2013b (MathWorks, Natick, MA) ( Fig. 1) . Finally, mean MTR asym (APT mean ), the 90th percentile of MTR asym (APT 90 ), standard deviation, kurtosis, and skewness of VOIs were calculated.
Histologic Evaluation
Pathological diagnosis was determined according to WHO 2007 criteria by a board-certified neuropathologist. 21 Grades 1 and 2
were regarded as low grade, while grades 3 and 4 were regarded as high grade.
Statistical Analysis
Data were checked by Gaussian distribution and homogeneity testing before analysis. Intrarater agreements were assessed with Cohen's kappa. If there was disagreement between the two raters, a third radiologist (T.O., a board-certified neuroradiologist with 24 years of experience) made the final decision. Correlations between parameters obtained from MRS and APT imaging were analyzed using Spearman correlation analysis. Receiver-operating characteristic (ROC) analyses were conducted to determine optimal thresholds, as well as sensitivity and specificity for grading brain tumors with each technique. We used conventional MRI characteristics as reference standards. Areas under the curve (AUCs) were statistically compared using a method described by Delong et al. 22 All statistical analyses were conducted using Stata v. 13 software (StataCorp, College Station, TX). Values of P < 0.05 were considered statistically significant.
Results
Patients
The patient population is summarized in Table 1 Intrarater Agreement of Conventional MRI Analyses by Neuroradiologists CE 1 ve was diagnosed in 16 patients, and CE 2ve was diagnosed in five patients (Table 1 ). Cohen's kappa was 1.0 and agreement was 100%.
Correlations Between MRS and APT Imaging
Correlations between among metabolites concentration or ratio from MRS and APT mean or APT 90 are summarized in Table 2 . Positive correlations with statistical significance were found between Cho and APT 90 , and between Cho/Cr and APT mean . Negative correlations with statistical significance were observed between NAA/Cr and APT mean . Negative correlations were observed between NAA and APT mean (r 5 20.43, P 5 0.05). Standard deviation, skewness, and kurtosis of APT asym showed no significant correlations with Cho, NAA Cr, or its ratios (Table 2) .
Diagnostic Capability for Grading Brain Tumors on Contrast Enhancement, MRS and APT Imaging ROC curves illustrating the performance of contrast enhancement, Cho, Cho/Cr, APT mean , APT 90 are shown in Fig. 3 . According to ROC curves, the APT mean cutoff of 2.72 offered the best combination of sensitivity (72.7%) and specificity (90%) in the characterization of high-grade gliomas, while the APT 90 cutoff of 6.61 demonstrated the optimal combination of sensitivity (90.9%) and specificity (70%).
Total concentration of Cho cutoff of 2.85 provided the best combination of sensitivity (63.6%) and specificity (100%) among total concentration of metabolites. Among the ratios of the two metabolites above, the Cho/Cr threshold value of 0.50 generated the best combination of sensitivity (100%) and specificity (93.8%) in the discrimination of high-and low-grade tumors. AUCs of each parameter are summarized in Table 3 . All the imaging parameters above except Cho demonstrated higher AUC values than that of contrast enhancement (AUC was 0.65). None of the AUCs obtained from these variables showed significant differences (Fig. 3, APT 90 vs. APT mean , P 5 0.74, APT 90 vs. Cho/Cr, P 5 0.35, Cho/Cr vs. APT mean , P 5 0.72). 
Discussion
We made two important observations in this study. First, we found significant moderate correlations between the concentration of metabolites and APT asym parameters. Few studies have investigated the associations among MRS and CEST. In the literature, lactate and MTR asym at 3.5 ppm correlated well with infarcted area in induced middle cerebral artery occlusion, 23 and a good correlation was seen between CEST at 2 ppm and creatine concentration for implanted gliosarcoma cells. 24 However, those studies used rat models, and only one clinical study has investigated correlations between MRS and CEST in human brain tumors. 19 Some investigators prefer APT 90 or other variables close to maximum values over mean APT values, 8, 19 because the 90% histogram cutoff is less influenced by random statistical fluctuations, and is thus considered superior to the maximum value. 25 When comparing Cho and APT 90 , a positive correlation was seen in patients with intra-axial brain tumors, supporting the recent results from Park et al. 19 These findings suggest the feasibility of quantitatively assessing similar biological characteristics in brain tumors using MRS and APT imaging as different modalities. Such correlation is unlikely to be due to signals from Cho, because the CEST effect at 3.5 ppm from endogenous metabolites including Cho and NAA might not be visible at 3T. Generally, malignant tumor cells show high proliferative activity and cellularity. The Cho peak corresponds to increased cell attenuation and membrane turnover in neoplastic tissues. 27, 28 APT values have recently been reported to show moderate correlations with cell density or MIB-1 index, as a representative marker for proliferative activity of the brain tumor. 9 A possible explanation for the positive correlation between Cho and APT 90 , therefore, involves the proliferative activity and cellularity of tumor cells. We also found a negative correlation between NAA and APT mean . NAA is predominantly located in neurons and is thus decreased in all neoplasms that cause neurons to be displaced or replaced with malignant cells. 29 Numerous studies have demonstrated decreased NAA peak, mainly in glial neoplasms 30 and primary CNS lymphoma, 31 consistent with our results. Our results also suggest that APT mean indirectly reflects neuronal loss due to brain tumor infiltration. To test our hypothesis, further study including stereotactic biopsy based on the APT image is needed. Interestingly, we neither found a positive correlation between Cho and APT mean , nor between NAA and APT 90 . A possible explanation for this discrepancy is that APT 90 and APT mean may be different biomarkers, and similar discrepancies were reported between minimum and mean apparent diffusion coefficient from diffusion-weighted imaging. 32 Jiang et al recently showed that the maximum value from APT imaging was significantly lower in patients with primary CNS lymphoma than in patients with glioblastoma, while APT mean values did not show any such significant differences between patient groups. 12 To clarify and verify different information for these parameters, further studies are needed. Second, MRS and APT imaging showed comparable diagnostic performance in differentiating between high-and low-grade brain tumors. Several studies have shown a significant increase in Cho/Cr in high-grade tumors compared with that of low-grade tumors at long TE with clinical scanners. 17, 18 Past studies also demonstrated the utility of that amount of metabolite or metabolite concentration ratio in grading brain tumor. 33 Recently, APT asym values were reportedly suitable for differentiating between high-and low-grade brain tumors, mainly in adult populations.
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The diagnostic capability of MRS and APT imaging for grading brain tumors was investigated and compared with that of conventional MRI in this study. We found that MRS and APT imaging shows higher AUCs compared with that of grading diagnosed by neuroradiologists based on conventional MRI. Although conventional MRI including CE-T 1 weighted image has been widely used in pre-and postoperative assessment of brain tumor, several researchers reported its limited capability of glioma-grading. 2, 3 Our result may suggest that these two imaging sequences can give us additional information of brain tumor even without contrast materials. Interestingly, metabolite ratios to creatine showed either better correlation with the APT value or diagnostic capability of glioma grading than the concentration. The reason is hard to explain. Previous study suggested that measuring concentrations of metabolites in brain tumor might be difficult, especially in high-grade glioma. 34 Metabolite ratios are frequently used in MRS studies and, assumed as an internal standard, can give us more accurate information in grading glioma than absolute concentration. 35 Our results may be in line with this. Our study had several limitations. First, despite several researches including the current study, the origin of APT Some authors implied or demonstrated that the background MT asymmetry or NOE effects are negligible at 3T, 10 while others argue that MT asymmetry is more significant than the APT effect even at 3T. 38 According to the recent researches with ultrahigh-field MRI, NOE imaging has the potential to delineate portions with high cellularity, or BBB disruption in glioma, without contrast agents. 39, 40 MT contrast in the brain tumor has been reported to be decreased compared with white matter, and correlate with nuclear density. 41 To investigate the association among NOE, MT asymmetry, and metabolites in brain tumors, further studies at ultrahigh-field MRI may be needed. Environmental factors such as pH and temperature also have great effects on the CEST image. pH imaging, which is a cutting-edge application of CEST, may become a potential marker of hypoxia. 42 A recent study showed the promising result of amine-proton based CEST images, which focuses on 3 ppm, in detecting intratumoral pH changes. 43 However, this effect is somewhat confusing in the assessment of brain tumor with APT images; high-grade tumors with high proliferation activity can show acidotic changes due to anaerobic metabolism or necrosis, which causes a lactate peak in MRS. 44 However, such acidotic change decreases the rate of proton exchange, and theoretically lessens the signal of tumors on APT image. Longo et al recently demonstrated this "Warburg effect" in breast cancer model mice, using two different modalities such as positron emission tomography and pH-oriented CEST image with iopamidol as an exogenous CEST contrast agent. 45 APT image combined with MRS, especially chemical shift imaging including lactate peak, may also offer complementary spatial information of the tumor microenvironment including pH and metabolism. Recent postprocessing advance, such as MT and relaxationnormalized APT, may give us additional information about intratumoral pH change. 46 Second, we did not adjust for APT imaging using controls, such as contralateral normalappearing white matter. Such adjustment might be useful for minimizing the effects of native MTR asym , discussed above. However, several studies have shown that diagnostic capability did not differ between imaging with and without such adjustment. 9, 11 In addition, some high-grade tumors may invade diffusely, leaving little normal-appearing white matter. 47 Third, some cases with glioblastoma showed relatively high Cramer Rao Lower Bounds (CRLB) (%SD is more than 15) in the NAA value. High-grade gliomas often show a low NAA peak due to glial cell invasion; as a result, fitting of a low amount of total NAA concentration may be difficult. Although NAA with larger CRLB in cases with glioblastoma might be unreliable and less reproducible, exclusion of cases with glioblastoma were not beneficial in this study. A strength of this study was the fact that, to clarify the correlation, the volume of interest was placed at the same location as the tumor on both MRS and APT imaging. To verify these correlations, a further study with direct comparison of histology obtained from stereotactic biopsy based on combined analysis using MRS and APT imaging may be warranted.
In conclusion, significant correlations were observed between metabolite concentrations and ratios on MRS and APT values. MRS and APT imaging showed comparable diagnostic capability for grading brain tumors, suggesting that both MRS and APT imaging offer potential for assessing the proliferative activity of brain tumors on noncontrast MRI.
